Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice
Crossref DOI link: https://doi.org/10.1371/journal.pone.0204366
Published Online: 2018-09-25
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Grosjean, Fabrizio
Yubero-Serrano, Elena M. http://orcid.org/0000-0002-2733-5359
Zheng, Feng
Esposito, Vittoria
Swamy, Shobha
Elliot, Sharon J.
Cai, Weijing
Vlassara, Helen
Salem, Fadi
Striker, Gary E.
Version of Record valid from 2018-09-25